A 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride DMF (Drug Master File) is a document detailing the whole manufacturing process of 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride active pharmaceutical ingredient (API) in detail. Different forms of 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride DMFs exist exist since differing nations have different regulations, such as 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride DMF submitted to regulatory agencies in the US is known as a USDMF. 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride USDMF includes data on 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 1,3-Bis-2,6-Diisopropylphenyl-Imidazolium Chloride suppliers with USDMF on PharmaCompass.